Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

67%

4 of 6 completed trials have results

Key Signals

1 recruiting4 with results

Enrollment Performance

Analytics

N/A

3(37.5%)

Early Phase 1

3(37.5%)

Phase 2

1(12.5%)

Phase 1

1(12.5%)

8Total

N/A(3)

Early Phase 1(3)

Phase 2(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT04334707Recruiting

Kidney Precision Medicine Project

Role: collaborator

NCT04151199Not ApplicableCompleted

Molecular Transducers of Physical Activity Consortium (MoTrPAC) - Pediatric Protocol

Role: collaborator

NCT03960827Not ApplicableCompleted

Molecular Transducers of Physical Activity Consortium

Role: collaborator

NCT03802721Early Phase 1Completed

Pharmacokinetics of Benzo[a]Pyrene: Impact of Diet

Role: collaborator

NCT03631667Early Phase 1Completed

Ultralow Dose PAH Binary Mixture Study

Role: collaborator

NCT03318978Early Phase 1Completed

Benzo[a]Pyrene Ultralow Dose-Response Study

Role: collaborator

NCT04590508Phase 2Active Not Recruiting

A Phase 2 Clinical Trial: Xanthohumol Metabolism and Signature (XMaS) in Crohn's Disease

Role: collaborator

NCT03735420Phase 1Active Not Recruiting

Xanthohumol Metabolism and Signature

Role: collaborator

NCT03925636Not ApplicableCompleted

Specific Carbohydrate Diet for Clostridium Difficile

Role: collaborator

NCT05384899Unknown

Kidney Precision Medicine Project (KPMP) - COVID-19 Protocol

Role: collaborator

All 10 trials loaded